Posts Tagged 'gsk'

GSK Official May Have Been Fired in Whistleblower Retaliation

gsk firing may have been whistleblower retaliationSome would say that when the manager of biostatistics of a multi-billion-dollar pharmaceutical corporation tells you that there is something wrong with the data you’re using to bring a drug to market, you might want to listen to that person. However, if allegations in a new lawsuit against GlaxoSmithKline are proven true, the other option is to try to get away with firing the biostatistician and move on.

Such are the ...

continue reading...

Zofran Maker Wants MDL for Birth Defect Lawsuits

GSK asks for Zofran MDLReuters reports that Zofran maker GlaxoSmithKline has asked the U.S. Judicial Panel on Multidistrict Litigation to centralize all pending Zofran birth defect lawsuits in a multidistrict litigation. The pharmaceutical giant has requested the Zofran lawsuits be consolidated in federal court in Pennsylvania, near the company’s U.S. headquarters.

Zofran is an antiemetic drug used to treat nausea and vomiting in chemotherapy, radiation therapy, and surgery patients. Zofran is also frequently prescribed to ...

continue reading...

GlaxoSmithKline Files to Create Zofran MDL

GSK files to consolidate zofran casesRecognizing the number of cases currently filed against it; and the potential for a significant number more, pharmaceutical giant GlaxoSmtihKline has requested that all Zofran birth defect lawsuits be consolidated into one multi-district litigation, or MDL.

MDLs are generally used as a tool for increasing the efficiency of of legal proceedings when a number of similar lawsuits are filed. When a large number of lawsuits are filed across a range of locations ...

continue reading...

GSK Warned over Vaccine Plant

GlaxoSmithKline received a warning from the U.S. Food and Drug Administration about the conditions at its manufacturing facility in Quebec. The FDA said that the plant violated quality requirements during the manufacturing of its influenza vaccine Flulaval.

The FDA sent a letter to the company on June 12 after an inspection of the plant earlier this year. The investigation found that GSK had not established and followed written procedures to prevent microbiological contamination of the ...

continue reading...

Foreign Investigators Linked to GlaxoSmithKline Indicted

Chinese prosecutors have indicted a foreign couple for the illegal collection of personal information by their private firm on behalf of drugmaker GalxoSmithKline last year. This is the first indictment announced by Chinese prosecutors of foreigners conducting an illegal investigation.

The couple, a 58 year old U.K. man and a 61 year old U.S. citizen, were indicted for illegally tracking personal information that had been obtained through hidden photography and “infiltration.” The data that was collected includes ...

continue reading...

GlaxoSmithKline to Pay $105 Million Settlement

GlaxoSmithKline paying 105 million dollar fine over false marketing claimsGlaxoSmithKline, a London-based pharmaceutical company, agreed to pay a $105 million settlement to 44 states and the District of Columbia. The company was allegedly unlawfully marketing Advair, its asthma drug, and two popular antidepressants.

The lawsuits claimed that GlaxoSmithKline was using off-label marketing and violated state consumer protection laws. Off-label marketing is when a company markets a drug for uses that are not approved by the ...

continue reading...
Page 1 of 2 12